Case number 1:21-cv-01621
Gilead Sciences, Inc. et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 16, 2024 | 211 | NOTICE requesting Clerk to remove Jeffrey Coleman, Hannah Lee, Jonathan R. Pepin, Marcus A. Colucci, and the law firm of KRAMER LEVIN NAFTALIS & FRANKEL LLP as co-counsel.. (Tigan, Jeremy) (Entered: 05/16/2024) (3) |
| Apr 30, 2024 | 210 | NOTICE of Change of Firm Affiliation for Daniel Williams and Christine Willgoos by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 04/30/2024) (4) |
| Apr 29, 2024 | 208 | MOTION for Pro Hac Vice Appearance of Attorney Raghav Krishnapriyan, Michael Scerbo and Ernest Fok - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 04/29/2024) (7) |
| Apr 29, 2024 | 209 | Pro Hac Vice Fee - Credit Card Payment received for Raghav Krishnapriyan, Michael Scerbo, and Ernest Fok. ( re 208 MOTION for Pro Hac Vice Appearance of Attorney Raghav Krishnapriyan, Michael Scerbo and Ernest Fok )( Payment of $ 150, receipt number ADEDC-4395160).(Tigan, Jeremy) (Entered: 04/29/2024) (0) |
| Apr 15, 2024 | 207 | NOTICE of Change of Firm Affiliation by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 04/15/2024) (4) |
| Apr 1, 2024 | 206 | REDACTED VERSION of 205 Letter by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 04/01/2024) (2) |
| Mar 26, 2024 | 204 | REDACTED VERSION of 201 Letter, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 03/26/2024) (2) |
| Mar 26, 2024 | 205 | [SEALED] Joint Letter to The Honorable Maryellen Noreika from the Parties regarding Trial. (Tigan, Jeremy) (Entered: 03/26/2024) (0) |
| Mar 19, 2024 | 202 | Letter to The Honorable Maryellen Noreika from John C. Phillips, Jr. regarding scheduling trial. (Phillips, John) (Entered: 03/19/2024) (1) |
| Mar 19, 2024 | 203 | ORAL ORDER Setting Teleconference re Letters ( 201 , 202 ): A Telephone Conference is set for 3/20/2024 at 03:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's Courtroom Deputy (Mark_Buckson@ded.uscourts.gov). ORDERED by Judge Maryellen Noreika on 3/19/2024. (mdb) (Entered: 03/19/2024) (0) |
| Mar 18, 2024 | 201 | [SEALED] Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Hearing on Lupin's Motion to Dismiss for Failure to State a Claim and Motion for Clarification - re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61, 200 Order Setting Hearing on Motion,,,. (Tigan, Jeremy) Modified on 3/19/2024 (mdb). (Entered: 03/18/2024) (0) |
| Mar 13, 2024 | 200 | ORAL ORDER Setting Hearing on 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 - IT IS HEREBY ORDERED that a Motion Hearing is set for 3/26/2024 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. The Court is setting aside 30 minutes for the argument with the time split equally between the parties. Any slide presentations the parties wish to use during the hearing shall be emailed (in PDF format) to MN_civil@ded.uscourts.gov no later than 24 hours prior to the hearing with hard copies delivered to the Clerk's Office within 1 hour thereafter. The parties may, however, agree upon a different time to exchange their respective slides. ORDERED by Judge Maryellen Noreika on 3/13/2024. (dlw) (Entered: 03/13/2024) (0) |
| Feb 9, 2024 | 199 | SO ORDERED re 198 Stipulation and Order to Amend Scheduling Order (pretrial order exchange deadlines; motion in limine deadlines). Signed by Judge Maryellen Noreika on 2/9/2024. (dlw) (Entered: 02/09/2024) (3) |
| Feb 8, 2024 | 198 | STIPULATION and [Proposed] Order to Amend Scheduling Order re 123 SO ORDERED,,, Set/Reset Scheduling Order Deadlines,, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 02/08/2024) (3) |
| Jan 30, 2024 | 196 | MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul and Richard T. Ruzich - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 01/30/2024) (4) |
| Jan 30, 2024 | 197 | Pro Hac Vice Fee - Credit Card Payment received for Andrew M. Alul and Richard T. Ruzich. ( re 196 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul and Richard T. Ruzich )( Payment of $ 100, receipt number ADEDC-4326091).(Dorsney, Kenneth) (Entered: 01/30/2024) (0) |
| Jan 24, 2024 | 194 | Letter to The Honorable Colm F. Connolly and The Honorable Maryellen Noreika from Kelly Farnan and John C. Phillips, Jr. regarding trial conflict. (Phillips, John) (Entered: 01/24/2024) (2) |
| Jan 24, 2024 | 195 | ORAL ORDER re 194 Letter - Having reviewed the parties' letter and having discussed the issue with Chief Judge Connolly, IT IS HEREBY ORDERED that the trial in this matter shall be RESET to begin on 6/24/2024. The Pretrial Conference is RESET for 6/17/2024 at 4:30 PM (Set/Reset Scheduling Order Deadlines: A Pretrial Conference is set for 6/17/2024 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 6/24/2024 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika). ORDERED by Judge Maryellen Noreika on 1/24/2024. (dlw) (Entered: 01/24/2024) (0) |
| Jan 18, 2024 | 193 | NOTICE to Take Deposition of Daniel R. Kuritzkes, M.D. on January 26, 2024 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/18/2024) (2) |
| Dec 27, 2023 | 192 | STIPULATION TO EXTEND TIME for the completion of expert discovery to January 26, 2024 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 12/27/2023) (2) |
| Dec 19, 2023 | 190 | NOTICE to Take Deposition of Dr. Graham Buckton on December 21, 2023 and January 16, 2024 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 12/19/2023) (5) |
| Dec 19, 2023 | 191 | NOTICE to Take Deposition of Dr. Chloe Thio on January 10, 2024 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 12/19/2023) (5) |
| Dec 13, 2023 | 189 | Supplemental Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Gilead Sciences, Inc.; Corporate Parent Gilead Sciences, Inc. for Gilead Sciences Ireland UC filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 12/13/2023) (4) |
| Dec 1, 2023 | 186 | NOTICE to Take Deposition of Robert O. Williams, III, Ph.D. on December 14, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/01/2023) (2) |
| Dec 1, 2023 | 187 | NOTICE to Take Deposition of Leah Appel, Ph.D. on December 8, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/01/2023) (2) |
| Dec 1, 2023 | 188 | NOTICE to Take Deposition of Greg Bell, Ph.D. on December 7, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/01/2023) (2) |
| Nov 29, 2023 | 185 | MOTION for Pro Hac Vice Appearance of Attorney Jeremiah S. Helm - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jeremiah S. Helm)(Bilson, David) (Entered: 11/29/2023) (0) |
| Nov 27, 2023 | 184 | NOTICE OF SERVICE of (1) [CONFIDENTIAL] Reply Expert Report of Graham Buckton Regarding Invalidity of US Patent 10,039,718; (2) [CONFIDENTIAL] Reply Expert Report of Graham Buckton Regarding Secondary Considerations Concerning US Patent 10,786,518; and (3) [CONFIDENTIAL] Reply Expert Report of Dr. Chloe Thio Regarding Invalidity of US Patent 10,786,518 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 11/27/2023) (2) |
| Nov 22, 2023 | 183 | NOTICE OF SERVICE of (1) Reply Expert Report of Leah Appel, Ph.D., Regarding US. 10,039,718; (2) Reply Expert Report of Robert O. Williams III, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. 10,786,518; (3) Reply Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding Infringement of U.S. Patent No. 10,786,518 and Objective Indicia of Non-Obviousness; and (4) Reply Report of Gregory K. Bell, PhD. filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 11/22/2023) (6) |
| Nov 16, 2023 | 182 | ORAL ORDER - IT IS HEREBY ORDERED that the parties shall engage in in-person mediation in good faith. The parties are to jointly hire an agreed-upon mediator. The timing of mediation efforts is left to the discretion of the parties, but the mediation must be conducted in advance of the pretrial conference. No later than one week before the pretrial conference, the parties shall submit a joint statement that identifies the mediator, the lead counsel for each party at the mediation and the length of the mediation, as well as a certification by the lead counsel that they have engaged in the mediation efforts in good faith. The joint statement should not disclose the substance of any offers, counteroffers or other negotiations. If the parties anticipate any further mediation efforts will be conducted after the deadline to submit the joint statement, the parties shall indicate that in their submission and state when those efforts are expected to occur. ORDERED by Judge Maryellen Noreika on 11/16/2023. (dlw) (Entered: 11/16/2023) (0) |
| Oct 20, 2023 | 181 | NOTICE OF SERVICE of [CONFIDENTIAL] Rebuttal Report of Graham Buckton Regarding Secondary Considerations of US Patent 10,039,718; [CONFIDENTIAL] Rebuttal Report of Graham Buckton Regarding Secondary Considerations of US Patent 10,786,518; [CONFIDENTIAL] Rebuttal Expert Report of Ivan Hofmann; and [CONFIDENTIAL] Responsive Expert Report of Dr. Chloe Thio Regarding Alleged Infringement and Secondary Considerations of US Patent 10,786,518 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 10/20/2023) (2) |
| Oct 19, 2023 | 180 | NOTICE OF SERVICE of (1) Rebuttal Expert Report of Leah Appel, Ph.D., Regarding U.S. 10,039,718; (2) Rebuttal Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding Validity of U.S. Patent No. 10,786,518; and (3) Rebuttal Expert Report of Robert O. Williams III, Ph.D., Regarding the Validity of U.S. Patent No. 10,786,518 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 10/19/2023) (6) |
| Oct 10, 2023 | 179 | ANSWER to 163 Answer to Complaint, Counterclaim by Gilead Sciences, Inc..(Tigan, Jeremy) (Entered: 10/10/2023) (6) |
| Oct 9, 2023 | 175 | REDACTED VERSION of 172 Reply Brief, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certificate of Service)(Phillips, John) (Entered: 10/09/2023) (0) |
| Oct 9, 2023 | 176 | REDACTED VERSION of 173 Declaration, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 15-17, # 2 Certificate of Service)(Phillips, John) (Entered: 10/09/2023) (0) |
| Oct 9, 2023 | 177 | REDACTED VERSION of 168 Answering Brief in Opposition, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 10/09/2023) (28) |
| Oct 9, 2023 | 178 | REDACTED VERSION of 169 Declaration, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Attachments: # 1 Ex. 1, # 2 Ex. 2, # 3 Ex. 3, # 4 Ex. 4)(Tigan, Jeremy) (Entered: 10/09/2023) (0) |
| Oct 5, 2023 | 174 | REQUEST for Oral Argument by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61. (Phillips, John) (Entered: 10/05/2023) (2) |
| Oct 2, 2023 | 171 | STIPULATION TO EXTEND TIME for Plaintiffs to file redacted versions of their Answering Brief in Opposition to Defendants' Motion to Dismiss (D.I. 168) and Declaration in Support of their Answering Brief in Opposition to Defendants' Motion to Dismiss (D.I. 169) to October 9, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 10/02/2023) (2) |
| Oct 2, 2023 | 172 | [SEALED] REPLY BRIEF re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certificate of Service)(Phillips, John) (Entered: 10/02/2023) (0) |
| Oct 2, 2023 | 173 | [SEALED] Supplemental DECLARATION of Jonathan Bachand re 172 Reply Brief by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. (Attachments: # 1 Exhibits 15-17, # 2 Certificate of Service)(Phillips, John) Modified on 10/3/2023 (dlw). (Entered: 10/02/2023) (0) |
| Sep 26, 2023 | 170 | STIPULATION TO EXTEND TIME for: (1) Rebuttal Expert Reports to October 19, 2023; (2) Reply Expert Reports to November 22, 2023; and (3) Completion of Expert Discovery to January 5, 2024 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 09/26/2023) (2) |
| Sep 25, 2023 | 168 | [SEALED] ANSWERING BRIEF in Opposition re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.Reply Brief due date per Local Rules is 10/2/2023. (Tigan, Jeremy) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 169 | [SEALED] DECLARATION of Marcus A. Colucci re 168 Answering Brief in Opposition by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Tigan, Jeremy) Modified on 9/26/2023 (dlw). (Entered: 09/25/2023) (0) |
| Sep 22, 2023 | 166 | ANSWER to Complaint // MSN's Answer regarding C.A. No. 23-774 Complaint by MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. (Hitch, Cortlan) Modified on 9/25/2023 (dlw). (Entered: 09/22/2023) (29) |
| Sep 22, 2023 | 167 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Pharmaceuticals, Inc. for MSN Laboratories Private Ltd. filed by MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Hitch, Cortlan) (Entered: 09/22/2023) (2) |
| Sep 20, 2023 | 165 | MOTION for Pro Hac Vice Appearance of Attorney Christine Willgoos - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 09/20/2023) (5) |
| Sep 18, 2023 | 163 | ANSWER to 1 Complaint, COUNTERCLAIM // regarding C.A. No. 23-774 Complaint against Gilead Sciences Ireland UC by Apotex Inc., Apotex Corp. (Hitch, Cortlan) Modified on 9/19/2023 (dlw). (Entered: 09/18/2023) (30) |
| Sep 18, 2023 | 164 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc.; Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 09/18/2023) (1) |
| Aug 29, 2023 | 160 | REDACTED VERSION of 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order, # 2 Proposed Order, # 3 Certificate of Service)(Phillips, John) (Entered: 08/29/2023) (0) |
| Aug 29, 2023 | 161 | REDACTED VERSION of 155 Opening Brief in Support, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certificate of Service)(Phillips, John) (Entered: 08/29/2023) (0) |
| Aug 29, 2023 | 162 | REDACTED VERSION of 156 Declaration, by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-14)(Phillips, John) (Entered: 08/29/2023) (0) |
| Aug 25, 2023 | 159 | STIPULATION TO EXTEND TIME for Defendants to file redacted versions of their Motion for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief from D.I. 61 and supporting documents to August 29, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 08/25/2023) (2) |
| Aug 24, 2023 | 158 | STIPULATION TO EXTEND TIME for Plaintiffs to file their opposition to Defendants' Motion to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief from D.I. 61 (D.I. 153) to September 22, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 08/24/2023) (2) |
| Aug 21, 2023 | 157 | NOTICE OF SERVICE of Plaintiff Gilead Sciences, Inc's Initial Rule 26 Disclosures - filed by Gilead Sciences, Inc..(Tigan, Jeremy) (Entered: 08/21/2023) (6) |
| Aug 18, 2023 | 153 | [SEALED] MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Text of Proposed Order, # 3 Certificate of Service)(Phillips, John) Modified on 8/21/2023 (dlw). (Entered: 08/18/2023) (0) |
| Aug 18, 2023 | 154 | NOTICE OF SERVICE of (1) Apotex and MSN's Initial 26(a) Disclosures and; (2) Apotex and MSN's Paragraph 3 Disclosures filed by Apotex Corp., Apotex Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Dorsney, Kenneth) (Main Document 154 replaced on 8/21/2023) (dlw). (Main Document 154 replaced on 8/21/2023) (dlw). (Entered: 08/18/2023) (3) |
| Aug 18, 2023 | 155 | [SEALED] OPENING BRIEF in Support re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. Answering Brief/Response due date per Local Rules is 9/1/2023. (Attachments: # 1 Certificate of Service)(Phillips, John) Modified on 8/21/2023 (dlw). (Entered: 08/18/2023) (0) |
| Aug 18, 2023 | 156 | [SEALED] DECLARATION of Jonathan E. Bachand re 153 MOTION to Dismiss for Failure to State a Claim Regarding U.S. Patent No. 10,786,518 and Motion for Clarification or Relief From D.I. 61 by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-9, # 2 Exhibit 10-11, # 3 Exhibit 12-14)(Phillips, John) Modified on 8/21/2023 (dlw). (Entered: 08/18/2023) (0) |
| Aug 14, 2023 | 152 | SO ORDERED re (151 in 1:21-cv-01621-MN, 12 in 1:23-cv-00774-MN) Stipulation and Order of Infringement and Consolidation. Signed by Judge Maryellen Noreika on 8/14/2023. (dlw) (dlw). (Entered: 08/14/2023) (6) |
| Aug 11, 2023 | 151 | STIPULATION of Infringement and Consolidation and [Proposed] Order by Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 08/11/2023) (6) |
| Aug 10, 2023 | 149 | NOTICE OF SERVICE of (1) Opening Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding Infringement of U.S. Patent No. 10,786,518 and Objective Indicia of Non-obviousness, (2) Opening Expert Report of Robert O. Williams, Ph.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. 10,786,518, (3) Expert Report of Gregory K. Bell, PhD,, (4) Opening Expert Report of Dr. Daniel R. Kuritzkes, M.D. Regarding U.S. Patent No. 10,039,718, (5) Opening Expert Report of Leah Appel, Ph.D., Regarding Validity of U.S. Patent No. 10,039,718 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 08/10/2023) (6) |
| Aug 10, 2023 | 150 | NOTICE OF SERVICE of the [CONFIDENTIAL] Expert Report of Dr. Chloe Lynne Thio, M.D. Regarding the Validity of U.S. Patent No. 10,786,518, the [CONFIDENTIAL] Expert Report of Graham Buckton, Ph.D., D.Sc. Regarding the Enablement of Prior Art to U.S. Patent No. 10,786,518, and the [CONFIDENTIAL] Expert report of Graham Buckton, Ph.D., Sc. Regarding the Validity of U.S. Patent No. 10,039,718 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/10/2023) (2) |
| Aug 3, 2023 | 148 | NOTICE to Take Deposition of Pramod Dahibhate on August 6, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 08/03/2023) (5) |
| Jul 31, 2023 | 146 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company's Third Set of Requests (Nos. 105-122) for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) Modified on 8/1/2023 (vfm). (Main Document 146 replaced on 8/1/2023) (vfm). (Entered: 07/31/2023) (2) |
| Jul 31, 2023 | 147 | NOTICE OF SERVICE of (1) Apotex's responses to Plaintiffs' First Set of Interrogatories (Nos. 1, 3 and 7-19); (2) Apotex's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-3, 8, 9, 14, 15, 17, 26, 27, 29, 30, 37-41); and (3) Apotex's responses to Plaintiffs' First Set of Requests for Admission (Nos. 3-10) filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 07/31/2023) (3) |
| Jul 25, 2023 | 145 | NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Second Supplemental Response to Plaintiffs' Interrogatories (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 07/25/2023) (2) |
| Jul 21, 2023 | 144 | NOTICE OF SERVICE of Defendant Apotex Corp.'s Objections and Responses to Plaintiffs' Notice of Subpoena filed by Apotex Corp..(Dorsney, Kenneth) (Entered: 07/21/2023) (3) |
| Jul 20, 2023 | 143 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' Supplemental Notice of Deposition to Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) (Topics 1-31) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 07/20/2023) (2) |
| Jul 7, 2023 | 140 | NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited, and Defendants Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc.s [CONFIDENTIAL] Invalidity Contentions and Objections and Responses to Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland Uc, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Companys Second Set of Requests (Nos. 84-104) for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John) (Entered: 07/07/2023) (2) |
| Jul 7, 2023 | 141 | NOTICE OF SERVICE of Defendants [CONFIDENTIAL] Invalidity Contentions Regarding U.S. Patent No. 10,039,718 (the 718 Patent) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John) (Entered: 07/07/2023) (2) |
| Jul 7, 2023 | 142 | NOTICE OF SERVICE of Reference Documents in Support of Defendants' Joint Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) (Entered: 07/07/2023) (3) |
| Jul 5, 2023 | 139 | NOTICE of Change of Address for Hannah Lee by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 07/05/2023) (5) |
| Jul 3, 2023 | 138 | ANSWER to 124 Answer to Complaint,, Counterclaim, --Plaintiffs' Answer to Lupin Limited's Counterclaims-- by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 07/03/2023) (10) |
| Jun 30, 2023 | 130 | NOTICE to Take Deposition of Rajiv Khurana on July 19, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5) |
| Jun 30, 2023 | 131 | NOTICE to Take Deposition of Jason Gensburger on July 28, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5) |
| Jun 30, 2023 | 132 | NOTICE to Take Deposition of Dr. Kiran Krishnan on July 17, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5) |
| Jun 30, 2023 | 133 | NOTICE to Take Deposition of Navin Vaya on July 18, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5) |
| Jun 30, 2023 | 134 | NOTICE to Take Deposition of Apotex Inc. and Apotex Corp. on July 19, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (13) |
| Jun 30, 2023 | 135 | NOTICE of Subpoena to Apotex Corp. by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company (Tigan, Jeremy) (Entered: 06/30/2023) (23) |
| Jun 30, 2023 | 136 | NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Interrogatories (Nos. 1-19) to Apotex Inc. and Apotex Corp.; (2) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Requests (Nos. 1-46) for the Production of Documents and Things to Apotex Inc. and Apotex Corp.; and (3) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Requests for Admission (Nos. 1-13) to Apotex Inc. and Apotex Corp. filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (6) |
| Jun 30, 2023 | 137 | NOTICE OF SERVICE of (1) Plaintiffs' Third Set of Requests (Nos. 105-122) to Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals, Inc. for the Production of Documents and Things and (2) Plaintiffs' Supplemental Notice of Deposition to Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/30/2023) (5) |
| Jun 29, 2023 | 129 | MOTION for Pro Hac Vice Appearance of Attorney Daniel Williams - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 06/29/2023) (5) |
| Jun 26, 2023 | 127 | STIPULATION and [Proposed] Order to Consolidate by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 06/26/2023) (5) |
| Jun 26, 2023 | 128 | SO ORDERED re (127 in 1:21-cv-01621-MN, 37 in 1:22-cv-01399-MN) Stipulation and Order to Consolidate. Signed by Judge Maryellen Noreika on 6/26/2023. SEE STIPULATION FOR FURTHER AND COMPLETE DETAILS (dlw) (Entered: 06/26/2023) (5) |
| Jun 22, 2023 | 126 | STIPULATION TO EXTEND TIME for Plaintiffs to answer, move, or otherwise respond to Defendants' counterclaims (D.I. 124) to July 6, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 06/22/2023) (2) |
| Jun 7, 2023 | 125 | NOTICE OF SERVICE of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Second Set of Requests (Nos. 84-104) for the Production of Documents and Things filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 06/07/2023) (4) |
| Jun 1, 2023 | 124 | ANSWER to Complaint filed in 23-508-MN (D.I. 1), Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by MSN Laboratories Private Ltd., Lupin Limited, MSN Life Sciences Private Ltd., Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. (Phillips, John) Modified on 6/2/2023 (dlw). (Entered: 06/01/2023) (30) |
| May 22, 2023 | 123 | [SEALED] SO ORDERED re (7 in 1:23-cv-00508-MN, 122 in 1:21-cv-01621-MN) Stipulation and Order to Consolidate (Set/Reset Scheduling Order Deadlines - Fact Discovery completed by 7/31/2023. Opening Expert Reports due by 8/10/2023. Rebuttal Expert Reports due by 10/5/2023. Reply Expert Reports due by 11/9/2023. Expert Discovery due by 12/22/2023. Daubert Motions due by 1/5/2024. A Pretrial Conference is set for 5/6/2024 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 5/13/2024 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 5/22/2023. This order has been emailed to local counsel. (dlw) (Entered: 05/22/2023) (0) |
| May 19, 2023 | 122 | [SEALED] STIPULATION and [Proposed] Order to Consolidate by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) Modified on 5/19/2023 (dlw). (Main Document 122 replaced on 5/19/2023) (dlw). (Entered: 05/19/2023) (0) |
| May 4, 2023 | 120 | STIPULATION TO EXTEND TIME for Certain Expert Discovery Deadlines to Various Dates - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 05/04/2023) (2) |
| May 4, 2023 | 121 | NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Supplemental Rule 26 Disclosures and (2) Plaintiffs' Second Supplemental Response to Defendants' Interrogatory (No. 1) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 05/04/2023) (4) |
| May 3, 2023 | 118 | STIPULATION TO EXTEND TIME for Certain Expert Discovery Deadlines to Various Dates - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 05/03/2023) (2) |
| May 3, 2023 | 119 | ORAL ORDER re 118 STIPULATION TO EXTEND TIME for Certain Expert Discovery Deadlines to Various Dates - IT IS HEREBY ORDERED that the stipulation is DENIED with leave to renew for failure to comply with Rule 16.4 of the Local Rules of Civil Practice and Procedure of the United States District Court for the District of Delaware. ORDERED by Judge Maryellen Noreika on 5/3/2023. (dlw) (Entered: 05/03/2023) (0) |
| Apr 21, 2023 | 117 | STIPULATION TO EXTEND TIME for: (1) Rebuttal Expert Report Deadline to May 8, 2023 and (2) Reply Expert Report Deadline to June 19, 2023 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 04/21/2023) (2) |
| Apr 17, 2023 | 116 | NOTICE requesting Clerk to remove Andrew M. Morrell as co-counsel. Reason for request: no longer affiliated with the case. (Bilson, David) (Entered: 04/17/2023) (2) |
| Mar 13, 2023 | 115 | NOTICE OF SERVICE of the [CONFIDENTIAL] Expert Report of Graham Buckton, Ph.D. and the [HIGHLY CONFIDENTIAL] Expert Report of Chloe Thio, M.D. filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 03/13/2023) (2) |
| Mar 10, 2023 | 114 | NOTICE OF SERVICE of Opening Expert Report of Dr. Daniel R. Kuritzkes, M.D. filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 03/10/2023) (4) |
| Feb 27, 2023 | 113 | MOTION for Pro Hac Vice Appearance of Attorney Aryeh N. Feinstein - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Aryeh N. Feinstein)(Bilson, David) (Entered: 02/27/2023) (Main Document) (2) |
| Feb 27, 2023 | 113 | MOTION for Pro Hac Vice Appearance of Attorney Aryeh N. Feinstein - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Aryeh N. Feinstein)(Bilson, David) (Entered: 02/27/2023) (Certification of Aryeh N. Feinstein) (1) |
| Feb 24, 2023 | 111 | NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Supplemental Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 4-23) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 02/24/2023) (2) |
| Feb 24, 2023 | 112 | NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatory (No. 7) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/24/2023) (4) |
| Feb 23, 2023 | 110 | NOTICE to Take Deposition of Rajeshwar Reddy Sagyam on March 2, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/23/2023) (4) |
| Feb 21, 2023 | 109 | NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatories (2, 5-7) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/21/2023) (4) |
| Feb 16, 2023 | 108 | MOTION for Pro Hac Vice Appearance of Attorney Marcus A. Colucci - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 02/16/2023) (4) |
| Feb 15, 2023 | 107 | NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatories (6-7, 10) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/15/2023) (4) |
| Feb 6, 2023 | 105 | NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' Third Set of Interrogatories (15-16) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Ying, Jennifer) (Entered: 02/06/2023) (4) |
| Feb 6, 2023 | 106 | NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-25) and Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 4-23) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 02/06/2023) (2) |
| Feb 2, 2023 | 104 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-25) and (2) Plaintiffs' Responses to Defendants' Second Set of Interrogatories (Nos. 13-14) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 02/02/2023) (4) |
| Jan 30, 2023 | 102 | NOTICE OF SERVICE of (1) Plaintiffs' Validity Contentions Regarding the '718 Patent and (2) Plaintiffs' Final Validity Contentions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/30/2023) (4) |
| Jan 30, 2023 | 103 | NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited and Defendants Lupin Pharmaceuticals, Inc. MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s [CONFIDENTIAL] Non-Infringement Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/30/2023) (2) |
| Jan 27, 2023 | 101 | STIPULATION TO EXTEND TIME for the parties to serve Final Non-Infringement and Validity Contentions to January 30, 2023, at noon E.T. - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 01/27/2023) (2) |
| Jan 25, 2023 | 100 | MOTION for Pro Hac Vice Appearance of Attorney Jared C. Bunker - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jared C. Bunker)(Bilson, David) (Entered: 01/25/2023) (Main Document) (2) |
| Jan 25, 2023 | 100 | MOTION for Pro Hac Vice Appearance of Attorney Jared C. Bunker - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Jared C. Bunker)(Bilson, David) (Entered: 01/25/2023) (Certification of Jared C. Bunker) (1) |
| Jan 24, 2023 | 99 | NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Supplemental Response to Plaintiffs' Interrogatories (No. 2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/24/2023) (2) |
| Jan 20, 2023 | 96 | NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) (Topics 1-53) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/20/2023) (2) |
| Jan 20, 2023 | 97 | STIPULATION and [Proposed] Order to Extend Time Regarding Certain Scheduling Order Deadlines by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 01/20/2023) (2) |
| Jan 20, 2023 | 98 | SO ORDERED re 97 Stipulation and Order to Extend Time (Set/Reset Scheduling Order Deadlines: Final Non-Infringement/Validity Contentions due 1/27/2023. Fact Discovery completed by 2/24/2023. Opening Expert Reports due by 3/10/2023. Rebuttal Expert Reports due by 4/24/2023. Reply Expert Reports due by 5/29/2023. Expert Discovery due by 7/7/2023). Signed by Judge Maryellen Noreika on 1/20/2023. (dlw) (Entered: 01/20/2023) (2) |
| Jan 19, 2023 | 95 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/19/2023) (4) |
| Jan 13, 2023 | 94 | REDACTED VERSION of 91 Notice to Take Deposition, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 01/13/2023) (17) |
| Jan 6, 2023 | 93 | NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Third Set of Interrogatories (Nos. 4-23) to Defendants and (2) Plaintiffs' First Set of Requests for Admission (Nos. 1-25) - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) Modified on 1/6/2023 (dlw). (Entered: 01/06/2023) (4) |
| Jan 5, 2023 | 91 | [SEALED] NOTICE to Take Deposition of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals, Inc. on January 24, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/05/2023) (0) |
| Jan 5, 2023 | 92 | NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Third Set of Interrogatories (Nos. 15-16) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/05/2023) (2) |
| Jan 4, 2023 | 83 | NOTICE to Take Deposition of Debashis Mohanty on January 23, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 4, 2023 | 84 | NOTICE to Take Deposition of Jason Gensburger on January 25, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 4, 2023 | 85 | NOTICE to Take Deposition of Makrand Avachat on January 30, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 4, 2023 | 86 | NOTICE to Take Deposition of Komati Satyanarayana on January 27, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 4, 2023 | 87 | NOTICE to Take Deposition of Pramod Dahibhate on February 1, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 4, 2023 | 88 | NOTICE to Take Deposition of Rajiv Khurana on February 3, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 4, 2023 | 89 | NOTICE to Take Deposition of Sanjay Wagh on February 6, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 4, 2023 | 90 | NOTICE to Take Deposition of Suneela Prodduturi on February 8, 2023 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 01/04/2023) (4) |
| Jan 3, 2023 | 82 | NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Second Set of Interrogatories (Nos. 13-14) and Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s First Set of Requests for Admission to Plaintiffs (Nos. 1-25) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 01/03/2023) (2) |
| Dec 22, 2022 | 71 | NOTICE to Take Deposition of Katia Boven on January 27, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 72 | NOTICE to Take Deposition of Sandeep Mathur on January 25, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 73 | NOTICE to Take Deposition of Karen Gerry on January 23, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 74 | NOTICE to Take Deposition of Goedele de Smedt on February 1, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 75 | NOTICE to Take Deposition of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company Under Federal Rule of Civil Procedure 30(b)(6) on a mutually agreed upon date filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (14) |
| Dec 22, 2022 | 76 | NOTICE to Take Deposition of Richard Yu on February 10, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 77 | NOTICE to Take Deposition of Margo Cooper on January 20, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 78 | NOTICE to Take Deposition of William Pyrz on February 8, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 79 | NOTICE to Take Deposition of Joanna Koziara on February 6, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 80 | NOTICE to Take Deposition of Dominiek Henrist on February 3, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 22, 2022 | 81 | NOTICE to Take Deposition of Roel Mertens on January 30, 2023 filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/22/2022) (2) |
| Dec 16, 2022 | 70 | NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Supplemental Response to Plaintiffs' Interrogatories (Nos. 1-3) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 12/16/2022) (2) |
| Dec 5, 2022 | 68 | NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 12/05/2022) (4) |
| Dec 5, 2022 | 69 | NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited, and Defendants Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc's [CONFIDENTIAL] Invalidity Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John) (Entered: 12/05/2022) (2) |
| Nov 28, 2022 | 67 | STIPULATION TO EXTEND TIME for Contentions to December 5, 2022 and January 20, 2023 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Bilson, David) (Entered: 11/28/2022) (2) |
| Nov 22, 2022 | 66 | NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants' Interrogatories (6-7) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 11/22/2022) (4) |
| Nov 16, 2022 | 65 | NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses to Defendants' Interrogatories (1-12) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 11/16/2022) (4) |
| Nov 7, 2022 | 61 | SO ORDERED re 59 Stipulation of Infringement and Order. Signed by Judge Maryellen Noreika on 11/7/2022. (dlw) (Entered: 11/07/2022) (6) |
| Nov 7, 2022 | 62 | AMENDED Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,039,718 B2; 10,786,518 B2. U.S. Patent Nos. 8,497,396 B2 and 9,428,473 B2 dismissed from suit pursuant to D.I. 61. (dlw) (Entered: 11/07/2022) (1) |
| Nov 7, 2022 | 63 | SO ORDERED re 60 Stipulation and Order to Amend Scheduling Order (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 2/10/2023. Opening Expert Reports due by 3/3/2023. Rebuttal Expert Reports due by 4/17/2023. Reply Expert Reports due by 5/22/2023. Expert Discovery due by 6/30/2023). ORDERED by Judge Maryellen Noreika on 11/7/2022. (dlw) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 64 | MOTION for Pro Hac Vice Appearance of Attorney Jeffrey Coleman, Ph.D. - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 11/07/2022) (4) |
| Nov 4, 2022 | 59 | STIPULATION of Infringement and [Proposed] Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 11/04/2022) (6) |
| Nov 4, 2022 | 60 | STIPULATION and [Proposed] Order to Amend Scheduling Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 11/04/2022) (2) |
| Oct 3, 2022 | 58 | STIPULATION TO EXTEND TIME for the substantial completion of document production to October 17, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 10/03/2022) (2) |
| Sep 21, 2022 | 57 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses to Defendants' Interrogatories Nos. 1, 2, 5, 6 and 11 filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 09/21/2022) (3) |
| Aug 25, 2022 | 56 | MOTION for Pro Hac Vice Appearance of Attorney Darish Huynh - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 08/25/2022) (4) |
| Aug 22, 2022 | 55 | NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Supplemental Identification of Prior Art References filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Main Document 55 replaced on 8/23/2022) (dlw). (Entered: 08/22/2022) (2) |
| Aug 19, 2022 | 53 | NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Identification of Intrinsic and Extrinsic Evidence to Oppose Plaintiffs' Proposed Constructions of Disputed Terms filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/19/2022) (2) |
| Aug 19, 2022 | 54 | NOTICE OF SERVICE of Plaintiffs' Identification of Intrinsic and Extrinsic Evidence to Oppose Defendants Proposed Constructions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) (Entered: 08/19/2022) (3) |
| Aug 11, 2022 | 52 | NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs Second Set of Interrogatories (No. 3) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/11/2022) (2) |
| Aug 9, 2022 | 51 | NOTICE OF SERVICE of Defendants Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) (Entered: 08/09/2022) (2) |
| Aug 5, 2022 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Initial Disclosure of Proposed Claim Terms for Construction filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Phillips, John) |
| Aug 5, 2022 | 50 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Claim Constructions and Supporting Intrinsic and Extrinsic Evidence filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| Jul 28, 2022 | 47 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Certain Case Deadlines to Various Dates - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) |
| Jul 28, 2022 | 48 | SO ORDERED (2) Docket Text: SO ORDERED re [47] STIPULATION TO EXTEND TIME for Certain Case Deadlines to Various Dates. Signed by Judge Maryellen Noreika on 7/28/2022. (dlw) |
| Jul 15, 2022 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s Initial Disclosure of Proposed Claim Terms for Construction filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| Jul 15, 2022 | 46 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company's Identification of Terms for Construction filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| Jul 12, 2022 | 44 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's Second Set of Interrogatories (No. 3) to Defendants filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| Jun 30, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [43] MOTION for Pro Hac Vice Appearance of Attorney Wayne Barsky, David Glandorf and Allyson Parks filed by Gilead Sciences, Inc., Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 6/30/2022. (dlw) |
| Jun 30, 2022 | 43 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wayne Barsky, David Glandorf and Allyson Parks - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy) |
| Jun 22, 2022 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-2) and Defendants' Objections and Responses to Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company's First Set of Requests (Nos. 1-83) for the Production of Documents and Things filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| Jun 15, 2022 | 41 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendants' First Set of Interrogatories (Nos. 1-12) and (2) Plaintiffs' Objections and Responses to Defendants' Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc.'s First Set of Requests for Production (Nos. 1-117) filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| Jun 8, 2022 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant/Counterclaimant Lupin Limited, and Defendants Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc.'s [CONFIDENTIAL] Initial Invalidity Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| May 9, 2022 | 38 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Interrogatories (Nos. 1-2) to Defendants and (2) Plaintiffs Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., and Janssen Sciences Ireland Unlimited Company's First Set of Requests (Nos. 1-83) for the Production of Documents and Things filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| May 9, 2022 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| May 2, 2022 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-117) and First Set of Interrogatories (Nos. 1-12) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| Apr 29, 2022 | 36 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Filko Prugo and Kelley Chandler and the law firm Ropes & Gray LLP as co-counsel.. (Tigan, Jeremy) |
| Apr 27, 2022 | 34 | Proposed Order (22) Docket Text: PROPOSED ORDER // Stipulated Protective Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) Modified on 4/27/2022 (dlw). |
| Apr 27, 2022 | 35 | Protective Order (22) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 4/27/2022. (dlw) |
| Apr 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [33] STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 27, 2022. ORDERED by Judge Maryellen Noreika on 4/22/2022. (dlw) |
| Apr 22, 2022 | 33 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 27, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Phillips, John) |
| Apr 21, 2022 | 32 | Notice (Other) (3) Docket Text: NOTICE of Change of Firm Affiliation by Gilead Sciences Ireland UC, Gilead Sciences, Inc. (Tigan, Jeremy) |
| Apr 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [29] STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 22, 2022. ORDERED by Judge Maryellen Noreika on 4/18/2022. (dlw) |
| Apr 18, 2022 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| Apr 15, 2022 | 29 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 22, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) |
| Apr 15, 2022 | 30 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraphs 3 and 4(a) of the Delaware Default Standard for Discovery - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| Apr 12, 2022 | 28 | Scheduling Order (14) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 11/18/2022. Amended Pleadings due by 11/18/2022. Fact Discovery completed by 12/19/2022. Opening Expert Reports due by 4/3/2023. Rebuttal Expert Reports due by 5/15/2023. Reply Expert Reports due by 6/12/2023. Expert Discovery due by 7/17/2023. Claim Construction Opening Brief served by 1/6/2023. Claim Construction Answering Brief served by 1/20/2023. Claim Construction Reply Brief served by 2/2/2023. Claim Construction Surreply Brief served by 2/10/2023. Joint Claim Construction Brief filed by 2/13/2023. A Markman Hearing is set for 3/10/2023 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 9/19/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 10/2/2023 at 08:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/12/2022. (dlw) |
| Apr 5, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [27] STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 15, 2022 filed by Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 4/5/2022. (mdb) |
| Apr 4, 2022 | 27 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to April 15, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) |
| Mar 30, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charlotte C. Jacobsen for Gilead Sciences Ireland UC and Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 28, 2022 | 26 | Proposed Order (14) Docket Text: Joint PROPOSED ORDER -- Revised [Proposed] Scheduling Order re [22] Oral Order, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) |
| Mar 23, 2022 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc..(Bilson, David) |
| Mar 23, 2022 | 25 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Jon Tanaka as co-counsel. Reason for request: No longer with firm. (Tigan, Jeremy) |
| Mar 22, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [21] Proposed Scheduling Order - IT IS HEREBY ORDERED that a 5-day bench trial in this matter will be set for 10/2/2023. On or before 3/29/2022, the parties shall submit a revised proposed Scheduling Order based on the 10/2/2023 trial date. ORDERED by Judge Maryellen Noreika on 3/22/2022. (dlw) |
| Mar 22, 2022 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Rule 26 Disclosures filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| Mar 15, 2022 | 21 | Main Document (14) Docket Text: PROPOSED ORDER // Scheduling Order by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Attachments: # (1) Letter to the Honorable Maryellen Noreika)(Tigan, Jeremy) Modified on 3/16/2022 (dlw). |
| Mar 15, 2022 | 21 | Letter to the Honorable Maryellen Noreika (1) |
| Mar 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] STIPULATION TO EXTEND TIME to submit a proposed Scheduling Order pursuant to the Court's February 8, 2022 Oral Order (D.I. 19) to March 15, 2022 filed by Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 3/11/2022. (mdb) |
| Mar 10, 2022 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed Scheduling Order pursuant to the Court's February 8, 2022 Oral Order (D.I. 19) to March 15, 2022 - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) |
| Feb 8, 2022 | 18 | Answer to Counterclaim (7) Docket Text: ANSWER to [15] Answer to Complaint,, Counterclaim, by Gilead Sciences Ireland UC, Gilead Sciences, Inc., Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company.(Tigan, Jeremy) |
| Feb 8, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiff serves its opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 2/8/2022. (dlw) |
| Jan 19, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew E. Morrell for Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jan 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [17] MOTION for Pro Hac Vice Appearance of Attorney William Zimmerman, Jonathan E. Bachand and Andrew E. Morrell, Ph.D. filed by MSN Life Sciences Private Ltd., MSN Laboratories Private Ltd., Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Pharmaceuticals Inc. ORDERED by Judge Maryellen Noreika on 1/18/2022. (dlw) |
| Jan 18, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William R. Zimmerman for Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jan 18, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan E. Bachand for Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jan 18, 2022 | 17 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William Zimmerman, Jonathan E. Bachand and Andrew E. Morrell, Ph.D. - filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of William Zimmerman, # (2) Certification of Jonathan E. Bachand, # (3) Certification of Andrew E. Morrell, Ph.D.)(Bilson, David) |
| Jan 18, 2022 | 17 | Certification of William Zimmerman (1) |
| Jan 18, 2022 | 17 | Certification of Jonathan E. Bachand (1) |
| Jan 18, 2022 | 17 | Certification of Andrew E. Morrell, Ph.D. (1) |
| Jan 17, 2022 | 15 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Lupin Pharmaceuticals, Inc., Lupin Limited, MSN Life Sciences Private Ltd. (Phillips, John) Modified on 1/18/2022 (dlw). |
| Jan 17, 2022 | 16 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Ltd. for MSN Pharmaceuticals Inc.; Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Phillips, John) |
| Dec 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [14] MOTION for Pro Hac Vice Appearance of Attorney Charlotte Jacobsen, Filko Prugo, Jon T. Tanaka and Kelley Chandler filed by Gilead Sciences, Inc., Gilead Sciences Ireland UC. ORDERED by Judge Maryellen Noreika on 12/21/2021. (dlw) |
| Dec 21, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Charlotte C. Jacobsen and Jon T. Tanaka for Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01621-MN, 1:21-cv-01615-MN(srs) |
| Dec 21, 2021 | 14 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charlotte Jacobsen, Filko Prugo, Jon T. Tanaka and Kelley Chandler - filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (Tigan, Jeremy) |
| Dec 17, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 13 has been replaced on the docket at the request of counsel. (dlw) |
| Dec 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [13] MOTION for Pro Hac Vice Appearance of Attorney Irena Royzman, Jonathan Pepin, and Hannah Lee filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. ORDERED by Judge Maryellen Noreika on 12/17/2021. (dlw) |
| Dec 17, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Hannah Lee, Jonathan R. Pepin, and Irena Royzman for Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Dec 16, 2021 | 13 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Irena Royzman, Jonathan Pepin, and Hannah Lee - filed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Main Document 13 replaced on 12/17/2021) (dlw). |
| Dec 15, 2021 | 12 | SO ORDERED (2) Docket Text: SO ORDERED re [11] STIPULATION TO EXTEND TIME for MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc. to answer, move, or otherwise respond to the Complaint to January 17, 2022 (Set/Reset Answer Deadlines: MSN Laboratories Private Ltd. answer due 1/17/2022; MSN Life Sciences Private Ltd. answer due 1/17/2022; MSN Pharmaceuticals Inc. answer due 1/17/2022). ORDERED by Judge Maryellen Noreika on 12/15/2021. (dlw) |
| Dec 14, 2021 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd. and MSN Pharmaceuticals Inc. to answer, move, or otherwise respond to the Complaint to January 17, 2022 - filed by MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc.. (Phillips, John) |
| Nov 24, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Nov 23, 2021 | 10 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC, Gilead Sciences, Inc.. MSN Pharmaceuticals Inc. served on 11/23/2021, answer due 12/14/2021. (Tigan, Jeremy) |
| Nov 22, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC, Gilead Sciences, Inc.: For Lupin Limited waiver sent on 11/18/2021, answer due 1/17/2022. (Tigan, Jeremy) |
| Nov 22, 2021 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company, Gilead Sciences Ireland UC, Gilead Sciences, Inc.: For Lupin Pharmaceuticals, Inc. waiver sent on 11/18/2021, answer due 1/17/2022. (Tigan, Jeremy) |
| Nov 18, 2021 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company filed by Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company. (nmg) |
| Nov 17, 2021 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 11/17/2021; Lupin Pharmaceuticals, Inc. on 11/17/2021; MSN Laboratories Private Ltd. on 11/17/2021; MSN Life Sciences Private Ltd. on 11/17/2021; MSN Pharmaceuticals Inc. on 11/17/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued)(mal) |
| Nov 17, 2021 | 6 | Summons Issued (2) |
| Nov 17, 2021 | 6 | Summons Issued (2) |
| Nov 17, 2021 | 6 | Summons Issued (2) |
| Nov 17, 2021 | 6 | Summons Issued (2) |
| Nov 16, 2021 | 1 | Main Document (32) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3744289.) - filed by Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(mal) . (Main Document 1 replaced on 11/17/2021) (nmg). |
| Nov 16, 2021 | 1 | Exhibit A-D (134) |
| Nov 16, 2021 | 1 | Civil Cover Sheet (1) |
| Nov 16, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Nov 16, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/06/2021. Date of Expiration of Patent: U.S. Patent No. 10,039,718 expires on 10/06/2032; U.S. Patent No. 10,786,518 expires on 07/19/2038; and U.S. Patent No. 8,497,396 expires on 10/30/2031; and U.S. Patent No. 9,428,473 expires on 04/01/2030. Thirty Month Stay Deadline: 4/6/2024. (mal) |
| Nov 16, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,497,396 B2 ;9,428,473 B2 ;10,039,718 B2 ;10,786,518 B2. (mal) |
| Nov 16, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Gilead Sciences, Inc. for Gilead Sciences Ireland UC filed by Gilead Sciences Ireland UC, Gilead Sciences, Inc.. (mal) |
| Nov 16, 2021 | 1 | Complaint* (1) |
